GlassScriptPhysician profile
Regina Phorn
NPI 1922650795
$1,230.40
in general payments reported to CMS, 2019-2025
29 companies · $104 in 2025
The $104 reported for 2025 was less than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $135 · 2022: $370 · 2023: $136 · 2024: $486 · 2025: $104.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $726.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $725.68 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Regeneron Healthcare Solutions, INC. | $144.52 | 2023-2024 | Libtayo |
| Takeda Pharmaceuticals U.S.A., INC. | $131.24 | 2022 | |
| Baxter Healthcare | $128.12 | 2023-2024 | Tisseel, Floseal, Perclot |
| Merit Medical Systems INC | $116.01 | 2021-2024 | Aeromini Stent and Delivery System, Elation Balloon Dilator |
| Merck Sharp & Dohme LLC | $87.03 | 2022-2025 | Keytruda, Lynparza |
| Incyte Corporation | $68.74 | 2022-2024 | Zynyz |
| Novartis Pharmaceuticals Corporation | $48.72 | 2024 | |
| Becton, Dickinson and Company | $39.10 | 2024 | Progel Applicator Spray Tips |
| Eisai INC. | $38.93 | 2022-2024 | |
| Genentech USA, INC. | $33.13 | 2025 | Itovebi |
| Astrazeneca Pharmaceuticals LP | $28.67 | 2023 | Lynparza |
| Glaxosmithkline, LLC. | $28.20 | 2022 | |
| Deciphera Pharmaceuticals INC. | $27.57 | 2022 | |
| Tersera Therapeutics LLC | $26.62 | 2022 | |
| Intuitive Surgical, INC. | $25.64 | 2021 |
Show all 29 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bayer Healthcare Pharmaceuticals INC. | $25.28 | 2024 | |
| Genmab U.S., INC. | $24.09 | 2024 | Epkinly |
| Abbvie INC. | $22.69 | 2024 | |
| Blueprint Medicines Corporation | $22.13 | 2021 | |
| Olympus America INC. | $21.65 | 2025 | Endoeye Flex Deflectable Videoscope |
| Atricure, INC. | $21.38 | 2022 | |
| Allergan, INC. | $20.06 | 2021 | |
| Biofrontera INC. | $17.64 | 2022 | |
| Caris Mpi, INC. | $16.66 | 2025 | Mi Cancer Seek |
| E.R. Squibb & Sons, L.L.C. | $16.45 | 2022 | |
| Ethicon US, LLC | $16.20 | 2025 | Stratafix, Surgicel Nu-Knit |
| Integra Lifesciences Corporation | $14.01 | 2024 | Integra, Integra Dermal Regeneration Template, Primatrix |
| Endogastric Solutions, INC | $9.96 | 2024 | Esophyx |
| Kls-Martin L.P. | $9.96 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Regina Phorn listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.